Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat hereditary angioedema (HAE) attacks, today announced ...

"Even with a decelerating growth rate on huge numbers, Nvidia's CY2025 PEG ratio stands at about 0.8x on our estimates. This ...

Nasdaq CEO Adena Friedman has a three-word piece of money advice for anyone who finds the investment market daunting. It’s ...

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of ...

Entero Therapeutics (ENTO) has entered into a binding term sheet for a reverse merger transaction with Journey Therapeutics. Upon completion of ...

The post-election rally has led stock exposure to jump to its highest level since 2013 amid a "surge in bulls," BofA says.

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, everyone. My name is Ashley and I will be your ...

“We need help,” he told NBC News this week, standing near the ruins of his business, Wedge Brewery. “We don’t need politics.” But a key source of federal aid may not be available any ...

Two members of Congress are pressing officials for answers after NBC News exposed failures to notify relatives of dead people whose bodies were used for medical research. The politicians also ...